LymeNet Flash: Dr Richard Horowitz Publishes Alzheimer/ Lyme Connection !

LymeNet on Facebook

LymeNet on Twitter

Follow @LymeDiseaseNet

The Lyme Disease Network receives a commission from Amazon.com for each purchase originating from this site.

When purchasing from Amazon.com, please
click here first.

Thank you.

Dedicated to the Bachmann Family

LymeNet needs your help:
LymeNet 2020 fund drive

The Lyme Disease Network is a non-profit organization funded by individual donations.

»	LymeNet Flash » Questions and Discussion » Medical Questions » Dr Richard Horowitz Publishes Alzheimer/ Lyme Connection !

UBBFriend: Email this page to someone!

Author

Topic: Dr Richard Horowitz Publishes Alzheimer/ Lyme Connection !

Bartenderbonnie
Frequent Contributor (1K+ posts)
Member # 49177

posted

We are so incredibly fortunate to have Dr Richard Horowitz!!!!

https://www.neurologylive.com/view/dapsone-combination-therapy-linked-alzheimer-biomarker-changes-single-lyme-disease-case-study

Neurology Live just reported on his article in the Journal of Alzheimer's Disease Reports! You can listen to the 6 min audio version. They highlight that this is the first time ever that anyone has lowered and reversed p-tau 217, the most specific and sensitive biomarker for Alzheimer's Disease using a 9 week oral antibiotic protocol that addresses the biofilm/persister forms of Borrelia!

“A 67-year-old with long-standing chronic Lyme disease received dapsone, rifampin, azithromycin, tetracycline, and methylene blue with supportive measures over nine weeks.

• Plasma p-tau217 fell 63% into the normalized range, and amyloid-B42/40 ratio increased, with reported improvements in recall and concentration.”

* reduction in plasma p-tau217 from 0.33 pg/mL to 0.12 pg/mL (63% decrease; normalized range)

• Improvement in amyloid-B 42/40 ratio from 0.185 to 0.216

• Reduction in rheumatoid factor from 20 IU/mL to within normal limits

These biomarker changes were accompanied by patient-reported improvements in cognition, including memory recall and concentration, as well as reduced joint symptoms.
Repeat laboratory testing conducted 2-3 months post-treatment confirmed normalization of inflammatory and neurodegenerative markers, including sustained reductions in p-tau217 and stable amyloid ratios.

Congratulations Dr Horowitz 💚❤️💚❤️💚❤️💚❤️💚❤️

Posts: 3217 | From Florida | Registered: Nov 2016 | IP: Logged |

hiker53
Moderator
Member # 6046

posted

Thanks, Bonnie, for posting this.

Autopsies of many Alzheimer's patients have shown Lyme in the brain for years.

Nice to have confirmation and some medical reversal.

--------------------
Hiker53

"God is light. In Him there is no
darkness." 1John 1:5

Posts: 10168 | From Illinois | Registered: Aug 2004 | IP: Logged |

Printer-friendly view of this topic

The Lyme Disease Network is a non-profit organization funded by individual donations. If you would like to support the Network and the LymeNet system of Web services, please send your donations to:

The Lyme Disease Network of New Jersey
907 Pebble Creek Court, Pennington, NJ 08534 USA
http://www.lymenet.org/